| P50 | author | Torsten Olbers | Q83789405 |
| | Lars Fändriks | Q91759362 |
| | Jamshid Alaghband-Zadeh | Q125298686 |
| | Malin Werling | Q125298688 |
| | Hans Lönroth | Q125298785 |
| | Royce P Vincent | Q125298787 |
| | Carel le Roux | Q19544968 |
| P2093 | author name string | Hanns-Ulrich Marschall | |
| | David R Taylor | |
| | Gemma F Cross | |
| P2860 | cites work | How do we define cure of diabetes? | Q42185262 |
| | Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes | Q42792518 |
| | Postprandial plasma bile acid responses in normal weight and obese subjects | Q42994410 |
| | Intracerebroventricular leptin regulates hepatic cholesterol metabolism | Q43003689 |
| | Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers | Q43205131 |
| | Quantitative analysis of bile acids in human plasma by liquid chromatography-electrospray tandem mass spectrometry: a simple and rapid one-step method | Q44716294 |
| | Rectal taurocholate increases L cell and insulin secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers | Q44964426 |
| | Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery. | Q45943724 |
| | Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides. | Q51373737 |
| | Cholestyramine therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. A short-term, double-blind, crossover trial. | Q51593713 |
| | Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression | Q24336351 |
| | The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control | Q24629879 |
| | Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity | Q26828547 |
| | The enzymes, regulation, and genetics of bile acid synthesis | Q28204726 |
| | Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery | Q29614192 |
| | The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance. | Q34094150 |
| | Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass surgery | Q34824270 |
| | Bile acids and cytokines inhibit the human cholesterol 7 alpha-hydroxylase gene via the JNK/c-jun pathway in human liver cells | Q34894300 |
| | Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass | Q35591749 |
| | Relation of depot-specific adipose inflammation to insulin resistance in human obesity. | Q35926642 |
| | Bile acids acutely stimulate insulin secretion of mouse β-cells via farnesoid X receptor activation and K(ATP) channel inhibition | Q35976675 |
| | Bariatric surgery versus intensive medical therapy in obese patients with diabetes | Q36025669 |
| | Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism | Q36381636 |
| | Activation of transmembrane bile acid receptor TGR5 stimulates insulin secretion in pancreatic β cells | Q36399942 |
| | Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids. | Q36736464 |
| | Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. | Q36914673 |
| | A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass | Q36942098 |
| | A surgical model in male obese rats uncovers protective effects of bile acids post-bariatric surgery. | Q36946081 |
| | Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum | Q36986629 |
| | Bile acids and the membrane bile acid receptor TGR5--connecting nutrition and metabolism | Q37085940 |
| | Role of bile acids and bile acid receptors in metabolic regulation | Q37363616 |
| | Bile-induced secretion of glucagon-like peptide-1: pathophysiological implications in type 2 diabetes? | Q37737870 |
| | Bile acid sequestrants: glucose-lowering mechanisms | Q37803229 |
| | Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders | Q37948701 |
| | Adipose tissue-resident immune cells: key players in immunometabolism. | Q38026316 |
| | Insulin-dependent suppression of cholesterol 7α-hydroxylase is a possible link between glucose and cholesterol metabolisms | Q39329298 |
| P433 | issue | 11 | |
| P304 | page(s) | 1257-1264 | |
| P577 | publication date | 2013-09-18 | |
| P1433 | published in | Scandinavian Journal of Gastroenterology | Q7429960 |
| P1476 | title | Enhanced fasting and post-prandial plasma bile acid responses after Roux-en-Y gastric bypass surgery | |
| P478 | volume | 48 | |